Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study.

Autor: Naranbhai V; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Dana-Farber Cancer Institute, Boston, MA.; Center for the AIDS Programme of Research in South Africa, Durban, South Africa., Pernat CA; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Gavralidis A; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Salem Hospital, Salem, MA., St Denis KJ; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA., Lam EC; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA., Spring LM; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Isakoff SJ; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Farmer JR; Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Zubiri L; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Hobbs GS; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., How J; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Division of Hematology, Brigham and Women's Hospital, Boston, MA., Brunner AM; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Fathi AT; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Peterson JL; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Sakhi M; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Hambelton G; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Denault EN; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Mortensen LJ; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Perriello LA; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Bruno MN; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Bertaux BY; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Lawless AR; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Jackson MA; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Niehoff E; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Barabell C; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Nambu CN; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Nakajima E; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Reinicke T; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Bowes C; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA., Berrios-Mairena CJ; Department of Pathology, Massachusetts General Hospital, Boston, MA., Ofoman O; Department of Pathology, Massachusetts General Hospital, Boston, MA., Kirkpatrick GE; Department of Pathology, Massachusetts General Hospital, Boston, MA., Thierauf JC; Department of Pathology, Massachusetts General Hospital, Boston, MA., Reynolds K; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Willers H; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA., Beltran WG; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA.; Department of Pathology, Massachusetts General Hospital, Boston, MA., Dighe AS; Department of Pathology, Massachusetts General Hospital, Boston, MA., Saff R; Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Blumenthal K; Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Sullivan RJ; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Chen YB; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Kim A; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA., Bardia A; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Balazs AB; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA., Iafrate AJ; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Department of Pathology, Massachusetts General Hospital, Boston, MA., Gainor JF; Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Jan 01; Vol. 40 (1), pp. 12-23. Date of Electronic Publication: 2021 Nov 09.

SARS-CoV-2-specific ELISA development.

Autor: Roy V; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, United States of America., Fischinger S; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, United States of America., Atyeo C; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, United States of America., Slein M; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, United States of America., Loos C; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, United States of America; Massachusetts Institute of Technology, Cambridge, MA 02139, United States of America., Balazs A; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, United States of America., Luedemann C; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, United States of America., Astudillo MG; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, United States of America., Yang D; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, United States of America., Wesemann DR; Brigham and Women's Hospital, Boston, MA 02115, United States of America., Charles R; Division of Infectious Disease, Massachusetts General Hospital, Boston, MA 02114, United States of America., Lafrate AJ; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, United States of America., Feldman J; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, United States of America., Hauser B; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, United States of America., Caradonna T; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, United States of America., Miller TE; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, United States of America., Murali MR; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, United States of America., Baden L; Brigham and Women's Hospital, Boston, MA 02115, United States of America., Nilles E; Brigham and Women's Hospital, Boston, MA 02115, United States of America., Ryan E; Division of Infectious Disease, Massachusetts General Hospital, Boston, MA 02114, United States of America., Lauffenburger D; Massachusetts Institute of Technology, Cambridge, MA 02139, United States of America., Beltran WG; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, United States of America; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, United States of America., Alter G; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, United States of America. Electronic address: galter@partners.org.

Publikováno v: Journal of immunological methods [J Immunol Methods] 2020 Sep - Oct; Vol. 484-485, pp. 112832. Date of Electronic Publication: 2020 Aug 08.

Sağlık Personelinin COVID-19 Antikor Pozitifliğinin Değerlendirilmesi. (Turkish)

Autor: KAYA, Selçuk, AKBAYIRLI, Ufuk, AKSOY GÖKMEN, Ayşegül, MÜDERRİS, Tuba, GÜL YURTSEVER, Süreyya

Publikováno v: Izmir Katip Celebi University Faculty of Health Sciences Journal / İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi; may2022, Vol. 7 Issue 2, p209-213, 5p

Blut und Blutkrankheiten : Teil 9 Blutgerinnung und Hämorrhagische Diathesen II Angeborene und Erworbene Koagulopathien

Autor: Dieter L. Heene